Companies/CN/002603

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. · 以岭药业

Last · Shenzhen¥15.89+0.02 (+0.13%)stale · yahoo · 74h ago
Market cap¥26.5B1.67B sh
P/E · TTM19.4fwd 14.6 · eps 0.82
Beta0.41vs S&P 500
Div yield5.08%annual · TTM
52w range
¥14.22¥21.58
Volume12.4Msession

Issuer

Legal nameSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. · 以岭药业
HQChina (CN)
ListingCN 002603
ISINCNE1000015S0
SectorHealthcare
IndustryPharmaceuticals
CurrencyCNY
Entity registryisin:CNE1000015S0
Org ID9900021072
Websitewww.yiling.cn
Employees11,343
AddressShijiazhuang Yiling Pharmaceutical Co., Ltd. No. 238 Tianshan Avenue 050035, Shijiazhuang +86 40 0789 8989
Headline financial metrics
Revenue¥5.4B
Operating income¥916.3M
Net income¥757.3M
Free cash flow¥1.1B
Operating margin17.0%
Net margin14.0%
Return on equity6.9%
PeriodTTM 2026-06-30
Loading chart…

Documents

FormReporting forFiledFlags
annual report以岭药业2025年年度报告 2c39a2fad44adf9IR
—2026-12-31≈0
10-Q
2026-06-302026-08-280
DISCLOSURE关于全资孙公司收到化学原料药欧洲CEP证书的公告
2026-08-262026-08-260
MGMT-HOLD-CHG董监高持股变动 · 002603 · 2026-07-21
2026-07-212026-07-210
DISCLOSURE关于公司及全资子公司专利产品进入《国家基本药物目录》（2026年版）的公告
2026-07-092026-07-090
Showing 5 of 185 filings